Views
4 years ago

09 - Agosto 2001

  • Text
  • Adolescencia
  • Depresion
  • Trastorno
  • Desarrollo
  • Grupo
  • Edad
  • Adolescentes
  • Eficacia
  • Tratamiento
  • Antidepresivos
  • Dosis
  • Psychiatry
Depresión y antidepresivos: Consideraciones en la niñez y la adolescencia

1. Ambrosini P J,

1. Ambrosini P J, Bianchi M D, Rabinovich H, Elia J: Antidepressant treatment in chodren and adolescents. Affective disorders. J Am Acad Child Adolesc Psychiatry 1993; 32: 1-6. 2. Anderan Jc. Mc Gee R: Comorbidity of depressión in children and adolescents New York, Plenum 1994: 581-601. 3. Awad G A: The use of selective serotonin reuptake inhibitors in young children with pervasive developmental disorder: some clinical observations. Can J Psychiatry 1996; 41: 361-6. 4. Baldessarini R J: Antipsychotic agents. American Psychiatric Association 1983. 5. Beasley C M Jr, Dornseif B E, Bosomworth J C, Sayler M E, Rampey A H Jr, Heiligenstein J H, Thompson V L, Murphy D J, Masica D N: Fluoxetine adn suicide: a meta-analysis of controlled trials of treatment for depressión. BMJ 1991; 303: 685-92. 6. Beasley C M Jr, Sayler M E, Weuss A M, Potvin J H: Fluoxetine: acticating and sedating effects at multiple fixed doses. J Clin Psychopharmacol 1992, 12: 328-33. 7. Berney T, Kolvin I, Bhate S R, Garside R F, Jeans J, Kay B, Scarth L: School phobia: a therapeutic trial with clomipramine and short-term outcome. Br J Psychiatry 1981; 138: 110-8. 8. Bernstein G A, Borchardt C M: Anxiety disorders of cholhood and adolecence: a critical review. J Am Acad Chold Adolesc Psychiatry 1991; 30: 519-32. 9. Biederman J, Thisted R A, Greenhill L , Ryan N D: Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. J Clin Psychiatry 1995; 56: 87-93. 10. Brent D: A major depressive disorder. New Dir Ment Health Serv. Summer 1992; 39-44. 11. Carroll B J: Dexamethasone suppressión test: a review of contemparary confusión. J Clin Psychiatry 1985; 46 (2 pt 2): 13-24. 12. Emslie G J, Rush A J, Weinberg W A, Kowatch R A, Hoghes C W, Carmody T, Rintelmann J: Double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depressión. Arch Gen Psychiatry 1997; 54: 1031-1037. 13. Finvard G. Depresión en niños y adolescentes. Vertex Rev. Arg. De Psiquiatría 1998; 9: 288-293. 14. Fleming J E, Offord D R: Epidemiology of choldhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry 1990; 29: 571-80. 15. Grubb B P, Somoil D, Kosinski D, Kip K, Brewster P: Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994; 24: 490-494. 16. Hazell p, o'Connell D, Heathcote D, Robertson J, Henry D: Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ 1995; 310; 897-901. 17. Hoehn-Saric R, Harris G J, Pearlson G D, Cox C S, Machlin S R, Camargo E E: A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient. J Clin Psychiatry 1991; 52: 131-133. 18. Kashani J H, Beck N C, Hoeper E W, Fallahi C, Corcoran C M, McAllister J A, Rosenberg T K, Reid J C: Psychiatric disorder in a community sample of adolescents. Am J Psychiatry 1987; 144: 584-589. 19. Kaxhani J H, Carlson G A, Beck N C, Hoeper E W, Corcoran C M, McAllister J A, Fallahi C, Rosenberg T K, Reid J C: Depressión, depressive sumptoms, and depressed mood among a community sample of adolescents. Am J Pscichiatry 1987; 144: 931-934. 20. Kashani J, Sherman D D: Childhood depression: Epidemiology, etiological models and treatment implications. Integr Psychiatry 1988; 6: 1-8. 21. King R A, Riddle M A, Chappell P B, Hardin M T, Anderson G M, Lombroso P, Scahill L: Emergence of sleft-destructive phenomena in chldren and adolescents durong fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 991; 30: 179-186. 22. Kovacs M, Feinberg T L, Crouse-Novak M, Paulauskas S L, Pollock M, Finkelstein R: Depressive disorder in childhood. II. A longitudinal study of the risk for a subsequent major depressión. Arch Gen Psychiatry 1984; 41: 643-649. 23. Kuhm R: The treatment of drepressive states with 622355 (imipramine hydrochloride). Am J Psychiatry 1958; 115: 459-464. 24. Lane R, Baldwin D: Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 197; 17: 208-221. 25. Leonard H L, Swedo S E, Lenane M C, Rettew D C, Chelsow D L, Hamburger S D, Rapoport J L: A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry 1991; 48: 922-927. 26. Leonard H L, Swedo S E, Repoport J L, Kovy E V, Lenane M C, Chelslow D L, Hamburger S D: Treatmente of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry 1989; 46: 1088-1092. 27. Lewinsohn O M, Clarke G N, Seeley J R, Rohde P: Major depressión in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 1994; 33: 809-818. 28. McKnew D H Jr, Cytryn L: Urinary metabolites in chronically depressed children. J Am Acad Child Psychiatry 1979; 18: 608-615.

29. Petti T A, Law W: 3rd: Abrupt cessation of hight-dose imipramine treatment in children. JAMA 1981; 246: 768-769. 30. Possaint A F, Ditmanks: A controlled study of imipramine in the treatment of choldhood enuresis. J Pediatr 1965; 67: 283-289. 31. Post R M: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999-1010. 32. Puig-Antich J: Affective disorder in children and adolescents. Diagnostic validity and psichobiology. En: Psychopharmacology, New York, Raven Press, 1997. 33. Puig-Antich J, Goetz D, Davies M, Kaplan T, Davies S, Ostrow L, Asnis L, Twomey J, Iyengar S, Ryan N D: A controlled family history study of prepubertal major depressive disorder. Arch Gen Paychiatry 1989; 46: 406-18. 34. Puig-Antich J, Perel J M, Lupatkin W, Chambers W J, Trabizi M A, King J, Goetz R, Davies M, Stiller R L: Imipramine in prepubertal major depressive disorder. Arch Gen Psychiatry 1987; 44: 81-89. 35. Rutter M, Izard C E, Read P B: Depressión in young People Clinical and Developmental Perspectives. Guilford, New York, USA; 1986: 3-30. 36. Ryan N D: Heterocyclic antidepressants in children and adolescents. J Child Adolsec Psychopharmacol 1990; 9: 21-31. 37. Ryan ND, Puig Antich J: Affective illness un adolescence. Annual review of the American Psychiatric Association, 1986. 38. Spencer T, Bierderman J, Wilens T, Harding M, O'Donnell D, Griffin S: Pharmacotherapy of attentiondeficit hyperactivity disorder across the life cycle. J Am Acad Chil Adolesc Psychiatry 1996; 35: 409-432. 39. Teicher M H, Glod C, Cole J O: Emergence of intense suicidal preocuppation during fluoxetine treatment. Am J Psychiatry 1990; 147: 207-210. 40. Tosyali M C, Greenhill L L: Child and adolescent psychopharmacology. Important developmental issues. Pediatr Clin North Am 1998; 45: 1021-1035. 41. Vitiello B, Jensen P S: Developmental perspectives in pediatric psychopharmacology, psychopharmacol Bull 1995, 31: 75-81. 42. Zajecka J, Tracy K A, Mitchell S: Disentination symptom after treatment with selective serotonin remptake inhibitors A literature review. J Clin Psychiatry 58: 291-297 1997.

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015